A randomized, active-controlled, parallel, open-label, multicenter, phase 4 study to compare the efficacy and safety of pregabalin sustained release tablet and pregabalin immediate release capsule in type II diabetic patients with peripheral neuropathic pain

Diabetic peripheral polyneuropathy is the most common chronic complication of type 2 diabetes. Neuropathic pain is challenging to manage, and various drugs are required to control it, decreasing treatment adherence. Pregabalin, a ligand that binds to alpha-2-delta subunits of the presynaptic calcium...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Seon Mee, Hong, Jun Hwa, Ku, Bon Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145715/
https://www.ncbi.nlm.nih.gov/pubmed/37115054
http://dx.doi.org/10.1097/MD.0000000000033701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145715/
https://www.ncbi.nlm.nih.gov/pubmed/37115054
http://dx.doi.org/10.1097/MD.0000000000033701

Ejemplares similares